Neurovir Therapeutics

Pioneering the development of HSV vectors for cancer therapy.

General Information
Company Name
Neurovir Therapeutics
Founded Year
-
Location (Offices)
+1
Founders / Decision Makers
Number of Employees
11-50
Industries
Biotechnology, Health Care
Funding Stage
-
Social Media

Neurovir Therapeutics - Company Profile

NeuroVir Therapeutics is a pioneering biopharmaceutical company specializing in the development of herpes simplex virus (HSV) vectors for cancer therapy. Their innovative approach in utilizing HSV vectors as cancer therapeutics positions them at the forefront of the biotechnology and healthcare industries.

Taxonomy: biopharmaceutical company, cancer therapy, HSV vectors, neurological therapeutics, oncolytic virotherapy

Funding Rounds & Investors of Neurovir Therapeutics (0)

View All

There is no investment information

Latest News of Neurovir Therapeutics

View All

No recent news or press coverage available for Neurovir Therapeutics.

Similar Companies to Neurovir Therapeutics

View All
Orogen Therapeutics - Similar company to Neurovir Therapeutics
Orogen Therapeutics Based in Woburn, Massachusetts, we create groundbreaking therapeutics with pioneering technologies.
CV Therapeutics - Similar company to Neurovir Therapeutics
CV Therapeutics
Tempest Therapeutics - Similar company to Neurovir Therapeutics
Tempest Therapeutics Pioneering the future of cancer treatment with innovative small molecule therapeutics that enhance anti-tumor immunity.
PIC Therapeutics - Similar company to Neurovir Therapeutics
PIC Therapeutics Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes
Iyuda Therapeutics - Similar company to Neurovir Therapeutics
Iyuda Therapeutics Leading the Fight Against Cancer, Infections, and Immune Disorders with Innovative Treatments
Circle Decoration Circle Decoration

Want to dive deeper into Neurovir Therapeutics? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now